Indiana

Indiana

State Facts

1,146

Deaths, or 67.9% of total overdose deaths involved opioids in 2024.¹

1.6 Million

Claims, or 4.64% of all Medicare Part D claims were for opioids in 2022 – an average of 64 per prescriber.²

49.4

Opioid Prescriptions were written for every 100 persons in Indiana in 2023.³

24,165

Beneficiaries on Medicare Part D had Opioid Use Disorder in 2022.⁴

Download FactSheet

Opioid Settlement Funds

$941,961,412.71
State Spending Recommendation

National approved use: providing support for non-opioid pain treatment alternatives, including training providers to offer or refer to multi-modal, evidence-informed treatment of pain.

Member & Endorser Footprint

Voices is backed by a broad coalition of organizations across the state united by a shared goal: ensuring patients have access to safe, effective, 
and individualized pain management throughout the continuum of care.

Co-Sponsors (119th)

Sen. Jim Banks (R-IN)

Sen. Jim Banks (R-IN)

2025 Introduced Relevant Legislation

HB 1358

This legislation ensures that Medicaid, the Children’s Health Insurance Program (CHIP), and private health insurance plans do not impose stricter coverage restrictions on FDA-approved non-opioid pain management drugs compared to opioids.

Introduced
01/13/2025
Plan Impact
Medicaid & Commercial
Learn More

Voices Letters

HB 1358 Hearing Request Sign On Letter

Learn More

1. Centers for Disease Control and Prevention (2025). Provisional Drug Overdose Death Counts. https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm

2. Centers for Disease Control and Prevention (2024). Medicare Part D Opioid Prescribing Mapping Tool. https://cms-oeda.maps.arcgis.com/apps/MapSeries/index.html?appid=5390718d875d4c049b1ac5976a9ff083

3. Center for Disease Control and Prevention (2024). Opioid Dispensing Rate Maps. https://www.cdc.gov/overdose-prevention/data-research/facts-stats/opioid-dispensing-rate-maps.html

4. Office of the Inspector General (2023). The Consistently Low Percentage of Medicare Enrollees Receiving Medication to Treat Their Opioid Use Disorder Remains a Concern. https://oig.hhs.gov/documents/evaluation/2722/OEI-02-23-00250-Complete%20Report.pdf